N Aaronson
Overview
Explore the profile of N Aaronson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
1363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bjelic-Radisic V, Cardoso F, Cameron D, Brain E, Kuljanic K, da Costa R, et al.
Ann Oncol
. 2020 Feb;
31(4):552.
PMID: 32089397
No abstract available.
2.
Bjelic-Radisic V, Cardoso F, Cameron D, Brain E, Kuljanic K, da Costa R, et al.
Ann Oncol
. 2020 Jan;
31(2):283-288.
PMID: 31959345
Background: The European Organization for Research and Treatment of Cancer (EORTC) QLQ-BR23 was one of the first disease-specific questionnaires developed in 1996 to assess quality of life (QoL) in patients...
3.
Bredart A, Kop J, Efficace F, Beaudeau A, Brito T, Dolbeault S, et al.
Psychooncology
. 2014 Sep;
24(4):382-94.
PMID: 25196048
Background: Cancer care is increasingly provided in the outpatient setting, requiring specific monitoring of care quality. The patients' perspective is an important indicator of care quality and needs to be...
4.
Rinkel R, Verdonck-de Leeuw I, van den Brakel N, de Bree R, Eerenstein S, Aaronson N, et al.
Oral Oncol
. 2014 Jun;
50(8):759-64.
PMID: 24954064
Objectives: To validate questionnaires on voice, speech, and swallowing among laryngeal cancer patients, to assess the need for and use of rehabilitation services, and to determine the association between voice,...
5.
Mitra A, Bancroft E, Barbachano Y, Page E, Foster C, Jameson C, et al.
BJU Int
. 2010 Sep;
107(1):28-39.
PMID: 20840664
Objective: To evaluate the role of targeted prostate cancer screening in men with BRCA1 or BRCA2 mutations, an international study, IMPACT (Identification of Men with a genetic predisposition to ProstAte...
6.
Bredart A, Coens C, Aaronson N, Chie W, Efficace F, Conroy T, et al.
Eur J Cancer
. 2006 Dec;
43(2):323-30.
PMID: 17156997
The aim of this study was to identify factors associated significantly with hospitalised cancer patients' satisfaction with care. Patients were recruited from four geographical/cultural groups, including five European countries and...
7.
Bjorner J, Petersen M, Groenvold M, Aaronson N, Ahlner-Elmqvist M, Arraras J, et al.
Qual Life Res
. 2005 Jan;
13(10):1683-97.
PMID: 15651539
Background: As part of a larger study whose objective is to develop an abbreviated version of the EORTC QLQ-C30 suitable for research in palliative care, analyses were conducted to determine...
8.
Van Putten J, Baas P, Codrington H, Kwa H, Muller M, Aaronson N, et al.
Lung Cancer
. 2001 Sep;
33(2-3):289-98.
PMID: 11551424
The aim of the study was to evaluate activity, toxicity and health-related quality of life (HRQL) with gemcitabine as second-line treatment after previous chemo- or radiotherapy in non-small-cell lung cancer...
9.
Langendijk H, de Jong J, Tjwa M, Muller M, Ten Velde G, Aaronson N, et al.
Radiother Oncol
. 2001 Mar;
58(3):257-68.
PMID: 11230886
Purpose: No randomized studies are available on the additional value of endobronchial brachytherapy (EBB) to external irradiation (XRT) regarding palliation of respiratory symptoms (RS). A prospective randomized study was initiated...
10.
Fossa S, Slee P, Brausi M, Horenblas S, Hall R, Hetherington J, et al.
J Clin Oncol
. 2001 Jan;
19(1):62-71.
PMID: 11134196
Purpose: Time to progression (TTP), overall survival, and quality of life (QL) were compared in patients with hormone-resistant prostate cancer (HRPC) treated with prednisone (5 mg orally, four times a...